Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conditioned place aversion produced by dopamine release inhibition

M D Schechter1, S M Meechan

  • 1Department of Pharmacology, Northeastern Ohio Universities College of Medicine, Rootstown 44272.

European Journal of Pharmacology
|August 1, 1994
PubMed
Summary

CGS 10746B, a dopamine release inhibitor, induced conditioned place aversion in rats at all tested doses. Higher doses also suppressed spontaneous locomotor activity, suggesting complex behavioral effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continued trends in the conditioned place preference literature from 1992 to 1996, inclusive, with a cross-indexed bibliography.

Neuroscience and biobehavioral reviews·1998
Same author

'Candyflipping': synergistic discriminative effect of LSD and MDMA.

European journal of pharmacology·1998
Same author

Olanzapine attenuates the reinforcing effects of cocaine.

European journal of pharmacology·1998
Same author

MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats.

Pharmacology, biochemistry, and behavior·1998
Same author

Rohypnol ("roofies") control of drug discrimination: effect of coadministered ethanol or flumenazil.

Pharmacology, biochemistry, and behavior·1998
Same author

LSD produces conditioned place preference in male but not female fawn hooded rats.

Pharmacology, biochemistry, and behavior·1998

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • CGS 10746B is a dopamine release inhibitor with properties resembling clozapine.
  • Understanding its behavioral effects is crucial for potential therapeutic applications.

Purpose of the Study:

  • To evaluate the behavioral effects of CGS 10746B.
  • To assess its impact on spontaneous locomotor activity and conditioned place preference in rats.

Main Methods:

  • Rats were administered varying doses of CGS 10746B (1.25-30.0 mg/kg).
  • Behavioral assessments included spontaneous locomotor activity and the conditioned place preference test.

Main Results:

  • A conditioned place aversion was observed across all tested doses of CGS 10746B.

Related Experiment Videos

  • Locomotor activity was suppressed by doses of 5.0 mg/kg and higher.

    • Conclusions:

    • CGS 10746B exhibits aversive properties and suppresses locomotor activity in rats.
    • Results highlight the role of dopaminergic pathways in conditioned place preference and locomotor activity, with methodological considerations for drug testing.